Nanostructured Lipid Carrier-Based Delivery of Pioglitazone for Treatment of Type 2 Diabetes

Pioglitazone (PGZ) is utilized as a therapeutic agent in the management of (type 2) diabetes to control blood glucose levels. The existing research work was intended to make and optimize PGZ-containing NLCs (nanostructured lipid carriers). The fabricated nanostructured lipid carrier preparation was...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilyas, Umair, Asif, Muhammad, Wang, Minglian, Altaf, Reem, Zafar, Hajra, Faran Ashraf Baig, Mirza Muhammad, Paiva-Santos, Ana Cláudia, Abbas, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315350/
https://www.ncbi.nlm.nih.gov/pubmed/35903327
http://dx.doi.org/10.3389/fphar.2022.934156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315350/
https://www.ncbi.nlm.nih.gov/pubmed/35903327
http://dx.doi.org/10.3389/fphar.2022.934156

Ejemplares similares